BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 24954725)

  • 1. Effect of liquid crystals with cyclodextrin on the bioavailability of a poorly water-soluble compound, diosgenin, after its oral administration to rats.
    Okawara M; Hashimoto F; Todo H; Sugibayashi K; Tokudome Y
    Int J Pharm; 2014 Sep; 472(1-2):257-61. PubMed ID: 24954725
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhancement of diosgenin distribution in the skin by cyclodextrin complexation following oral administration.
    Okawara M; Tokudome Y; Todo H; Sugibayashi K; Hashimoto F
    Biol Pharm Bull; 2013; 36(1):36-40. PubMed ID: 23302635
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of β-cyclodextrin derivatives on the diosgenin absorption in Caco-2 cell monolayer and rats.
    Okawara M; Tokudome Y; Todo H; Sugibayashi K; Hashimoto F
    Biol Pharm Bull; 2014; 37(1):54-9. PubMed ID: 24389481
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phytantriol and glyceryl monooleate cubic liquid crystalline phases as sustained-release oral drug delivery systems for poorly water-soluble drugs II. In-vivo evaluation.
    Nguyen TH; Hanley T; Porter CJ; Larson I; Boyd BJ
    J Pharm Pharmacol; 2010 Jul; 62(7):856-65. PubMed ID: 20636873
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nanostructured liquid crystalline particles provide long duration sustained-release effect for a poorly water soluble drug after oral administration.
    Nguyen TH; Hanley T; Porter CJ; Boyd BJ
    J Control Release; 2011 Jul; 153(2):180-6. PubMed ID: 21497623
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A lipid-based liquid crystalline matrix that provides sustained release and enhanced oral bioavailability for a model poorly water soluble drug in rats.
    Boyd BJ; Khoo SM; Whittaker DV; Davey G; Porter CJ
    Int J Pharm; 2007 Aug; 340(1-2):52-60. PubMed ID: 17467935
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel oral delivery system consisting in "drug-in cyclodextrin-in nanostructured lipid carriers" for poorly water-soluble drug: vinpocetine.
    Lin C; Chen F; Ye T; Zhang L; Zhang W; Liu D; Xiong W; Yang X; Pan W
    Int J Pharm; 2014 Apr; 465(1-2):90-6. PubMed ID: 24530388
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phytantriol and glyceryl monooleate cubic liquid crystalline phases as sustained-release oral drug delivery systems for poorly water soluble drugs I. Phase behaviour in physiologically-relevant media.
    Nguyen TH; Hanley T; Porter CJ; Larson I; Boyd BJ
    J Pharm Pharmacol; 2010 Jul; 62(7):844-55. PubMed ID: 20636872
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro and in vivo studies on the complexes of glipizide with water-soluble β-cyclodextrin-epichlorohydrin polymers.
    Nie S; Zhang S; Pan W; Liu Y
    Drug Dev Ind Pharm; 2011 May; 37(5):606-12. PubMed ID: 21469949
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Examining the gastrointestinal transit of lipid-based liquid crystalline systems using whole-animal imaging.
    Pham AC; Nguyen TH; Nowell CJ; Graham B; Boyd BJ
    Drug Deliv Transl Res; 2015 Dec; 5(6):566-74. PubMed ID: 26328930
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced oral bioavailability of flurbiprofen by combined use of micelle solution and inclusion compound.
    Li DX; Han MJ; Balakrishnan P; Yan YD; Oh DH; Joe JH; Seo Y; Kim JO; Park SM; Yong CS; Choi HG
    Arch Pharm Res; 2010 Jan; 33(1):95-101. PubMed ID: 20191350
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Formulation and development of bicontinuous nanostructured liquid crystalline particles of efavirenz.
    Avachat AM; Parpani SS
    Colloids Surf B Biointerfaces; 2015 Feb; 126():87-97. PubMed ID: 25543986
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination of β-cyclodextrin inclusion complex and self-microemulsifying drug delivery system for photostability and enhanced oral bioavailability of methotrexate: novel technique.
    Bourkaib N; Zhou J; Yao J; Fang Z; Mezghrani O
    Drug Dev Ind Pharm; 2013 Jun; 39(6):918-27. PubMed ID: 22998295
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mode of action of beta-cyclodextrin as an absorption enhancer of the water-soluble drug meglumine antimoniate.
    Martins PS; Ochoa R; Pimenta AM; Ferreira LA; Melo AL; da Silva JB; Sinisterra RD; Demicheli C; Frézard F
    Int J Pharm; 2006 Nov; 325(1-2):39-47. PubMed ID: 16876345
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amorphous ternary cyclodextrin nanocomposites of telmisartan for oral drug delivery: improved solubility and reduced pharmacokinetic variability.
    Sangwai M; Vavia P
    Int J Pharm; 2013 Sep; 453(2):423-32. PubMed ID: 22935741
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inclusion complexes of noscapine in beta-cyclodextrin offer better solubility and improved pharmacokinetics.
    Madan J; Dhiman N; Parmar VK; Sardana S; Bharatam PV; Aneja R; Chandra R; Katyal A
    Cancer Chemother Pharmacol; 2010 Feb; 65(3):537-48. PubMed ID: 19597818
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced bioavailability of soy isoflavones by complexation with beta-cyclodextrin in rats.
    Lee SH; Kim YH; Yu HJ; Cho NS; Kim TH; Kim DC; Chung CB; Hwang YI; Kim KH
    Biosci Biotechnol Biochem; 2007 Dec; 71(12):2927-33. PubMed ID: 18071265
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Physicochemical characteristics and bioavailability of a novel intestinal metabolite of ginseng saponin (IH901) complexed with beta-cyclodextrin.
    Lee PS; Han JY; Song TW; Sung JH; Kwon OS; Song S; Chung YB
    Int J Pharm; 2006 Jun; 316(1-2):29-36. PubMed ID: 16574357
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preparation, characterization and in vivo evaluation of formulation of baicalein with hydroxypropyl-beta-cyclodextrin.
    Liu J; Qiu L; Gao J; Jin Y
    Int J Pharm; 2006 Apr; 312(1-2):137-43. PubMed ID: 16459034
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced bioavailability of poorly water-soluble clotrimazole by inclusion with beta-cyclodextrin.
    Prabagar B; Yoo BK; Woo JS; Kim JA; Rhee JD; Piao MG; Choi HG; Yong CS
    Arch Pharm Res; 2007 Feb; 30(2):249-54. PubMed ID: 17366748
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.